FOXA1 and cholangiocarcinoma: Notably, shRNA-mediated knockdown of FOXA1 and FOXA2, along with sustained ETS1 expression, completely shifted HCC to intrahepatic cholangiocarcinoma development in primary liver cancer mouse models [22].